Press Releases

Date Title and Summary
Toggle Summary Accuray Announces Approval of the Accuray Precision® Treatment Planning System by China's National Medical Products Administration
MADISON, Wis. , June 12, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the Accuray   Precision ® Treatment Planning System (TPS) has been approved by the Chinese National Medical Products Administration (NMPA).
Toggle Summary Accuray to Participate in the Jefferies Global Healthcare Conference 2024
MADISON, Wis. , May 22, 2024 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Jefferies Global Healthcare Conference 2024. The management team is scheduled to participate in a fireside chat on Wednesday, June 5, 2024 at 7:30am EDT / 4:30am PDT     A live
Toggle Summary Accuray Reports Fiscal 2024 Third Quarter Financial Results
MADISON, Wis. , May 1, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter and nine-months ended March 31, 2024 .     Third Quarter Fiscal 2024 Summary Net revenue of $101.1 million decreased 14 percent from the same period in the prior
Toggle Summary Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024
Celebrates 30 Years of Innovation Through Collaboration and the Development of Technologies That Have Helped Set the Standard of Care for the Industry MADISON, Wis. , April 25, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company is showcasing advances in
Toggle Summary Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland
  The new center is the most recent addition to the company's existing training hubs in Madison, Wisconsin ( U.S. ), Tokyo, Japan and Tianjin, China     Each facility offers a range of educational opportunities designed to advance patient care using the Accuray CyberKnife ® and Radixact ® Systems
Toggle Summary Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024
MADISON, Wis. , April 17, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2024, ended March 31, 2024 , during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on May 1, 2024 .
Toggle Summary New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System
Data Also Underscores Potential Benefits of CyberKnife System Sub-millimeter Accuracy in Preserving Quality of Life after Treatment for Prostate Cancer MADISON, Wis. , March 26, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the 2024 Radiosurgery
Toggle Summary Accuray Incorporated to Speak at 36th Annual Roth Conference
Company to Take Part in Fireside Chat Monday , March 18, 2024 at 12:30pm PST / 3:30pm EST MADISON, Wis. , March 4, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY ) announced today its participation in the 36 th Annual Roth Conference . The management team is scheduled to take part in a
Toggle Summary Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference
Company to Take Part in Fireside Chat Tuesday, March 12, 2024 at 7:00am PST / 10:00am EST MADISON, Wis. , Feb. 27, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference taking place March
Toggle Summary Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System
Montérégie Integrated Cancer Center , part of Charles-LeMoyne Hospital , is a center of excellence and recognized leader in the treatment of cancer in the province of Quebec The Radixact System is equipped with ClearRT™ and Synchrony ® , advanced technologies designed to improve treatment outcomes

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.